Canadian Agency for Drugs and Technologies in Health. (2017). CADTH Canadian Drug Expert Committee final recommendation Edoxaban: Lixiana-Servier Canada Inc. : indication : venous thromboembolic events. Canadian Agency for Drugs and Technologies in Health.
Chicago Style (17th ed.) CitationCanadian Agency for Drugs and Technologies in Health. CADTH Canadian Drug Expert Committee Final Recommendation Edoxaban: Lixiana-Servier Canada Inc. : Indication : Venous Thromboembolic Events. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2017.
MLA (9th ed.) CitationCanadian Agency for Drugs and Technologies in Health. CADTH Canadian Drug Expert Committee Final Recommendation Edoxaban: Lixiana-Servier Canada Inc. : Indication : Venous Thromboembolic Events. Canadian Agency for Drugs and Technologies in Health, 2017.